214 related articles for article (PubMed ID: 12078123)
1. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
Lalosević V; Lazarević-Ivanc L; Lalosević D
Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
[TBL] [Abstract][Full Text] [Related]
2. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of BHK-rabies vaccine in human volunteers.
Lalosević D; Stankov S; Lazarević-Ivanc L; Lalosević V; Knezević I
Med Pregl; 1998; 51 Suppl 1():17-9. PubMed ID: 9769650
[TBL] [Abstract][Full Text] [Related]
4. [Economical production of rabies vaccine on cell cultures].
Lalosević D; Lazarević-Ivanc L; Stankov S
Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine for man.
Bijok U; Barth R; Gruschkau H; Vodopija I; Smerdel S; Kukla H; Geursen R
J Commun Dis; 1984 Mar; 16(1):61-9. PubMed ID: 12055789
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
[TBL] [Abstract][Full Text] [Related]
7. The present status of rabies vaccine development and clinical experience with rabies vaccine.
Roumiantzeff M
Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
[TBL] [Abstract][Full Text] [Related]
8. [A study on efficacy of rabies vaccine prepared by primary hamster kidney cells in Guangxi].
Wu T; Lu Y; Ge X
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):211-3. PubMed ID: 10322757
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of the large-scale use of PHKC rabies vaccine in humans in China.
Lin FT
Bull World Health Organ; 1990; 68(4):449-54. PubMed ID: 2208558
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers.
Mahendra BJ; Madhusudana SN; Ashwathnarayana DH; Sampath G; datta SS; Sudarshan MK; Venkatesh GM; Muhamuda K; Bilagumba G; Shamanna M
Vaccine; 2007 Dec; 25(50):8405-9. PubMed ID: 17981377
[TBL] [Abstract][Full Text] [Related]
12. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
Baysal B; Tosun S; Ozdemir M; Doğan M
Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
[TBL] [Abstract][Full Text] [Related]
14. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of purified Vero-cell rabies vaccine in severely rabies-exposed patients in China.
Wang XJ; Lang J; Tao XR; Shu JD; Le Mener V; Wood SC; Huang JT; Zhao SL
Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):287-94. PubMed ID: 11127328
[TBL] [Abstract][Full Text] [Related]
16. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
Dong G; Zheng H; Liu Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
[TBL] [Abstract][Full Text] [Related]
17. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
[TBL] [Abstract][Full Text] [Related]
19. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
[TBL] [Abstract][Full Text] [Related]
20. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
